MPL and Thrombocytopenia: Another characteristic feature of dengue infection is thrombocytopenia; current guidelines recommend avoiding NSAIDS and employing eltrombopag, a thrombopoietin receptor agonist, in dengue patients with moderate to severe thrombocytopenia [76].